Peroxisome proliferator-activated receptor activating hypoglycemic effect of Gardenia jasminoides Ellis aqueous extract and improvement of insulin sensitivity in steroid induced insulin resistant rats

Abstract

BackgroundThe active components of Gardenia (Gardenia jasminoides Ellis, GJ) exhibit a hypoglycemic effect by improving insulin secretion and lowering plasma lipids. In the present study, we fed a water extract of gardenia to steroid-induced insulin-resistant (SIIR) rats and observed changes in signaling proteins in order to elucidate the mechanisms of the insulin-sensitizing effect of GJ and evaluate its possibility as an insulin-sensitizing agent.MethodsNormal Wistar rats were randomly divided into a control group (i.e., saline) and experimental groups (GJ 100 and 200 mg/kg). Blood samples were taken at 0, 30, and 60 min for plasma glucose assay in order to determine the optimal dose to induce the hypoglycemic effect. SIIR rats were then randomly divided into a control group (i.e., saline) and an experimental group (optimal dose of gardenia extract) to observe the insulin-sensitizing effect of the extract. Finally, western blot analysis was performed to detect intracellular signaling proteins to elucidate the mechanisms of the insulin-sensitization effect of GJ.ResultsThe normal Wistar rats in the GJ 200 mg/kg group exhibited significant hypoglycemic activity. Meanwhile, the SIIR rats had higher plasma glucose levels than normal rats. There was no obvious change in insulin level, but the insulin sensitivity index and homeostasis model assessment index were significantly elevated. Meanwhile, a significant hypoglycemic effect was observed with GJ 200 mg/kg. In addition, intracellular signaling proteins including insulin receptor substrate-1 (IRS-1) and peroxisome proliferator-activated receptor (PPARγ) were elevated in muscle cells.ConclusionsThe optimal dose of GJ aqueous extract of 200 mg/kg exerts a PPARγ-activating hypoglycemic effect and improves insulin resistance in SIIR rats. Therefore, it is a potential insulin-sensitizing agent in type 2 diabetes mellitus with insulin resistance.

Rosuvastatin Alleviates Type 2 Diabetic Atrial Structural and Calcium Channel Remodeling

“…Insulin resistance was determined by insulin sensitivity index (ISI) and glucose tolerance. An ISI 17,18 {calculated as ln [1 · (FBG · FINS) 21 ]; FBG, fasting blood glucose; FINS, fasting insulin} was carried out to determine insulin sensitivity. Intraperitoneal glucose tolerance test was performed to assess glucose tolerance.…”

Improving insulin resistance with Antrodia cinnamomea mycelium powder to induce a hypoglycemic effect in dexamethasone‑induced insulin‑resistant rats

“…In addition to the aforementioned effects of AC, its therapeutic effects on insulin resistance have also been investigated (22)(23)(24), but the mechanism by which AC enhances insulin sensitivity has not been completely elucidated, particularly for steroid-induced insulin-resistance (SIIR) (25,26). Steroids are widely prescribed and are known to cause insulin resistance.…”

The Involvement of Serotonin in the Hypoglycemic Effects Produced by Administration of the Aqueous Extract of Xylaria nigripes with Steroid-Induced Insulin-Resistant Rats

“…For example, streptozotocin, alloxan (Matthews et al , ) with nicotinamide (Masiello et al , ), prednisolone (Kovalik et al , ), and dexamethasone (Taheri et al , ) can all induce hyperglycemia. In this study, a low‐dose (1 mg/kg) and long‐term (5 days) administration of dexamethasone induced insulin resistance; the dexamethasone was used as the therapeutic target (Chen et al , ). Because dexamethasone is widely used in medicine, the finding that it induces insulin resistance and results in high‐glucose levels represents a problem.…”

“…According to previously published research methods (Chen et al , 2014a, 2014b), the SIIR rats were injected with dexamethasone, 1 mg/kg intraperitoneal (i.p.) daily for 5 days.…”